This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Verve Therapeutics is trying to swerve the gene editing industry downturn with n...
Commerce Secretary Howard Lutnick has indicated more specific timelines as to wh...
Pfizer has discontinued its once-daily obesity pill danuglipron after a patient ...
The study has demonstrated the potential of predictable movement stimuli as a be...
Cigna Healthcare ranks highest among commercial health plans when it comes to di...
The combination of Bristol Myers Squibb cancer drugs Opdivo and Yervoy landed FD...
Welcome to the weekly edition of Healthcare IT Today Bonus Features. This articl...
Even as studies and personal experiences repeatedly reflect the effectiveness of...
At Medicarians 2025, MedCity News Editor-in-Chief Arundhati Parmar explored the ...
The goal of the Two-Midnight Rule, originally introduced under traditional Medic...
The healthcare business is one of the most competitive markets, with 82% of mark...
Welcome to our Healthcare IT Today Weekly Roundup. Each week, we’ll be providing...
Welcome back to Endpoints Weekly! This week's recap kicks off with Andrew Dunn's...
What You Should Know: – Endeavor Health, a Chicagoland-based integrated health ...
What You Should Know: – ATA Action, the advocacy arm of the American Telemedici...
What You Should Know: – Thoughtful.ai, a company specializing in artificial int...